Event Archives
| Event Name | Event Description | Event Dates | Event Location |
|---|---|---|---|
DIA 2020 Global Annual Meeting | Session: How Do You Oversee and Manage New Centralized/Remote/Site Monitoring Models? What Should You Measure to Gain Insights? Session Date: Monday, June 15, 2020 Session Moderator: Panelists: Joe Kunakorn, MS Charles Lawrence Liss, MS Barbara Novak
For additional information, please visit https://www.diaglobal.org/Flagship/DIA-2020 | 06/15/2020-06/15/2020 | |
Clinical Trial Innovation Summit | Date: April 6 – 8, 2020 Location: Cambridge, MA Track: Risk-based Monitoring Presentation: Is Your Centralized/Onsite Site Monitoring Program Being Implemented per ICH E6(R2)? How Do You Know? Linda Sullivan, Co-Founder & Executive Director, WCG-Metrics Champion Consortium
Roundtable Discussion: Implementation of Clinical Development Risk Management Linda Sullivan, Co-Founder & Executive Director, WCG-Metrics Champion Consortium Jonathan Rowe, Pfizer
| 04/06/2020-04/08/2020 | Cambridge, MA |
SCOPE | Track: Implementing Risk-Based Monitoring – Part 1 Date: February 19, 2020 Location: Orlando, FL Risk-based Quality Management Strategy 10:40 – 10:45 am Chairperson’s Remarks Linda Sullivan, Co-Founder & Executive Director, WCG-Metrics Champion Consortium
11:10 -11:35 am Co-Presentation: Bridging the Gap between Issue Management and Risk-based Quality Management Linda Sullivan, Co-Founder & Executive Director, WCG-Metrics Champion Consortium Ann McCabe, Director, Process Excellence & Risk Management, Daiichi Sankyo, Inc.
2020 Interactive Breakout Discussions OUTSOURCING, STRATEGIC PARTNERSHIPS, AND KPIS Date: February 19, 2020 from 4:20 – 5:10 pm Table 22: Vendor Performance Metrics and KPIs
Moderators: Keith Dorricott, Ambassador, Metrics Champion Consortium; Director, DMPI Ltd.
Track: Managing Outsourced Clinical Trials Date: February 21, 2020 Vendor Oversight: Metrics, KPIs and ICH E6 R2 8:25 – 8:55 am Presentation: Defining Metrics for Quality Vendor Oversight Keith Dorricott, Ambassador, WCG-Metrics Champion Consortium | 02/18/2020-02/21/2020 | Orlando, FL |
The Drug Development Workforce in the Age of Digital Transformation | Date: December 4, 2019 from 9:30am – 3:30pm Location: Pfizer, New York, NY Panelist: Linda Sullivan, Co-Founder & Executive Director, WCG-Metrics Champion Consortium | 12/04/2019-12/04/2019 | Pfizer - NewYork, NY |
Clinical Trials Europe | Date: November 21, 2019 Session Title: “The Impact of Risk-based Quality Management on Vendor Oversight” Session Participant: Keith Dorricott, Contractor for Metrics Champion Consortium (MCC) | 11/21/2019-11/21/2019 | Barcelona, Spain |
MAGI’s Clinical Research Conference – 2019 West | Date: October 27, 2019 Session Title: Sponsors of Choice/Sites of Choice: Measuring What Matters Session Information: In this working group, we will employ a structured process for defining the key attributes, metrics and performance levels that make a sponsor or site a great partner. This working group is open to people who want to participate, not just observe.
Session Title: Site, Sponsor and CRO Metrics and Benchmarking Session Information: Measure the performance of your partners and your own organization.
| 10/27/2019-10/27/2019 | Las Vegas, Nevada |
Risky Business Forum | Date: September 20, 2019 Session Title: “Risk Evaluation and Control – Meeting the Requirements of ICH E6 (R2) A worked example with Keith Dorricott, Metrics Champion Consortium Ambassador” Session Participant: Keith Dorricott, Contractor for Metrics Champion Consortium (MCC) | 09/20/2019-09/20/2019 | Uxbridge, UK |
Workshop: Building Capacity for Patient-Centered R&D | Date: September 16, 2019 Session Title: Measuring Success—What does it look like? Session Information: Moderator: Roslyn Schneider Session objective: Discuss how we can measure outcomes and effectiveness of patient capacity-building efforts and identify what aspects of capacity-building programs contribute to achieving success (e.g., clear focus on target audience, purpose/desired outcomes, method for deploying training, cost/sustainability, multi-stakeholder participation).
| 09/16/2019-09/16/2019 | Washington D.C. |
MCC Clinical Trial Risk and Performance Management Summit | Date: September 4-5, 2019
Come to the Clinical Trial Risk and Performance Management Summit and discover the secrets to implementing a successful metrics program. You’ll unlock the secrets to deciding what to measure; establishing your data requirements; aggregating reliable data; designing easy to understand metric reports; and using metrics to identify areas of concern and conduct root cause analysis. Check out this sampling of what you’ll explore over the course of an information-packed day-and-a-half:
| 09/04/2019-09/05/2019 | Philadelphia, PA |
Improving the Implementation of Risk-Based Monitoring Approaches of Clinical Investigations (public workshop) | Date: July 17, 2019 – 8:30 am to 4:00 pm FDA is seeking feedback from stakeholders on the challenges, barriers, and enablers that might be impacting the adoption of RBM, and related opportunities to improve RBM implementation. This public workshop, held under a cooperative agreement with the U.S. Food and Drug Administration, is an opportunity to capture stakeholder input on:
Session 5: Measuring the Impact of Risk-Based Monitoring Approaches Session Participant: Linda B Sullivan, Executive Director WCG-Metrics Champion Consortium | 07/17/2019-07/17/2019 | Washington, DC |
